Arterial Spin Labeling Blood Flow MRI for Evaluation of Response to Antiangiogenic and Targeted Therapies of Renal Cell Carcinoma (RCC)

NCT00749320 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Beth Israel Deaconess Medical Center

Collaborators